Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria
- PMID:16595824
- DOI: 10.1373/clinchem.2005.060772
Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria
Erratum in
- Clin Chem. 2006 Jun;52(6):1213
Abstract
Background: Diagnosis of an attack of acute intermittent porphyria (AIP) is based on the demonstration of increased concentrations of porphobilinogen (PBG) and delta-aminolevulinic acid (ALA) in urine, but many AIP patients also have high baseline concentrations in remission. The aim of this study was to estimate the biological variations of ALA, PBG, and porphyrins in healthy individuals and AIP patients to improve interpretation of test results.
Methods: Fifteen healthy individuals and 15 AIP patients were included, and biological variations were calculated based on urine samples collected weekly for 10 consecutive weeks. For the AIP patients, long-term variations were also estimated based on 7 samples collected through a 2-year period.
Results: The porphyrin variances were inhomogeneously distributed; biological variations of porphyrins were therefore not calculated. The within-subject biological variations of ALA and PBG were 16%-20% in the short-term settings and for PBG, 25% in the long-term setting, giving reference change values of approximately 50% and 70%, respectively. The probability of detecting a 100% real change in PBG was 97% in the short-term setting and 80% in the long-term setting.
Conclusions: In an AIP patient, a 2-fold increase in PBG, independent of the baseline concentration, will be detected with a probability >80% and is most likely related to the patient's disease and not caused only by analytical and biological variation. When PBG is used in the assessment of AIP-related symptoms, both the PBG concentration in remission and the length of time since the previous sample must be considered.
Similar articles
- Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.Floderus Y, Sardh E, Möller C, Andersson C, Rejkjaer L, Andersson DE, Harper P.Floderus Y, et al.Clin Chem. 2006 Apr;52(4):701-7. doi: 10.1373/clinchem.2005.058198. Epub 2006 Feb 23.Clin Chem. 2006.PMID:16497943
- Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.Kauppinen R, von und zu Fraunberg M.Kauppinen R, et al.Clin Chem. 2002 Nov;48(11):1891-900.Clin Chem. 2002.PMID:12406973
- Acute intermittent porphyria in childhood: a population-based study.Hultdin J, Schmauch A, Wikberg A, Dahlquist G, Andersson C.Hultdin J, et al.Acta Paediatr. 2003 May;92(5):562-8.Acta Paediatr. 2003.PMID:12839285
- Molecular diagnostics of acute intermittent porphyria.Kauppinen R.Kauppinen R.Expert Rev Mol Diagn. 2004 Mar;4(2):243-9. doi: 10.1586/14737159.4.2.243.Expert Rev Mol Diagn. 2004.PMID:14995910Review.
- Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria.Solares I, Jericó D, Córdoba KM, Morales-Conejo M, Ena J, Enríquez de Salamanca R, Fontanellas A.Solares I, et al.Int J Mol Sci. 2022 Dec 20;24(1):51. doi: 10.3390/ijms24010051.Int J Mol Sci. 2022.PMID:36613492Free PMC article.Review.
Cited by
- Porphyrias at a glance: diagnosis and treatment.Cappellini MD, Brancaleoni V, Graziadei G, Tavazzi D, Di Pierro E.Cappellini MD, et al.Intern Emerg Med. 2010 Oct;5 Suppl 1:S73-80. doi: 10.1007/s11739-010-0449-7.Intern Emerg Med. 2010.PMID:20865478Review.
- ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias.San Juan I, Pereira-Ortuzar T, Cendoya X, Laín A, To-Figueras J, Mateos B, Planes FJ, Bernardo-Seisdedos G, Mato JM, Millet O.San Juan I, et al.Biochemistry. 2022 Nov 1;61(21):2409-2416. doi: 10.1021/acs.biochem.2c00434. Epub 2022 Oct 14.Biochemistry. 2022.PMID:36241173Free PMC article.
- Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.Chen B, Solis-Villa C, Erwin AL, Balwani M, Nazarenko I, Phillips JD, Desnick RJ, Yasuda M.Chen B, et al.J Inherit Metab Dis. 2019 Jan;42(1):186-194. doi: 10.1002/jimd.12040.J Inherit Metab Dis. 2019.PMID:30740734Free PMC article.
- Regional Variation in Analytical Techniques used in the Diagnosis and Monitoring of Porphyria: a Case for Harmonisation?Sies CW, Cronin V, Florkowski CM, Gill J, Grant J, Poulos V, Zoanetti J.Sies CW, et al.Clin Biochem Rev. 2015 May;36(2):63-74.Clin Biochem Rev. 2015.PMID:26224896Free PMC article.
- Dental and Periodontal Health in Acute Intermittent Porphyria.Storjord E, Airila-Månsson S, Karlsen K, Madsen M, Dahl JA, Landsem A, Fure H, Ludviksen JK, Fjøse JØ, Dickey AK, Karlsen BO, Waage Nielsen E, Mollnes TE, Brekke OL.Storjord E, et al.Life (Basel). 2022 Aug 19;12(8):1270. doi: 10.3390/life12081270.Life (Basel). 2022.PMID:36013449Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous